NCT05374239

Brief Summary

Background: Using outcome measures is emphasized in foundational training and clinical practice guidelines, but less than 50% of rehabilitation professionals consistently use outcome measures in practice. No studies have evaluated the barriers to routine outcome measurement in Singapore's healthcare settings nor identified effective implementation strategies to sustain the use of outcome measures in practice. Aims: To evaluate the effectiveness of a tailored multi-component implementation intervention effectiveness in improving the consistency of use of the Fugl-Meyer Assessment of Upper Extremity (FMA) among occupational therapists practicing in 4 hospitals in Singapore. Method: The project will use the Normalisation Process Theory as a framework and data collection sites will include Singapore General Hospital, Sengkang General Hospital, Outram Community Hospital, and Sengkang Community Hospital. The investigators will use a stepped-wedge randomised trial design. The study will begin with an initial period in which no hospitals are exposed to the intervention. Subsequently, at regular intervals, one hospital will cross from the control to the intervention. The investigators will continue this process until the intervention is introduced to all hospitals. The intervention will be fully implemented by the end of the trial, with all 4 hospitals receiving the multi-component intervention. Project Significance: This trial is part of a larger project that uses a theory-driven approach to systematically explore the embedding and integration of outcome measures in routine clinical care for rehabilitation professionals in Singapore (beyond initial implementation stages). Study findings will contribute to the scientific knowledge base of implementing outcome measures in clinical practice, improve patient care, and support future implementation projects on outcome measurement in different populations and healthcare settings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 16, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

July 6, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 2, 2023

Completed
Last Updated

May 21, 2024

Status Verified

May 1, 2024

Enrollment Period

1.1 years

First QC Date

May 10, 2022

Last Update Submit

May 19, 2024

Conditions

Keywords

implementationoutcome measuresstroke

Outcome Measures

Primary Outcomes (1)

  • Adherence rate

    Average rate of adherence to the administration of the FMA by occupational therapists

    6 months post-intervention

Other Outcomes (3)

  • Acceptability of Intervention Measure (AIM)

    6 months post-intervention

  • Intervention Appropriateness Measure (IAM)

    6 months post-intervention

  • Feasibility of Intervention Measure (FIM)

    6 months post-intervention

Study Arms (4)

Hospital 1

OTHER

First hospital in the allocation sequence to cross from control to intervention arm.

Other: Multi-component implementation intervention

Hospital 2

OTHER

Second hospital in the allocation sequence to cross from control to intervention arm.

Other: Multi-component implementation intervention

Hospital 3

OTHER

Third hospital in the allocation sequence to cross from control to intervention arm.

Other: Multi-component implementation intervention

Hospital 4

OTHER

Fourth hospital in the allocation sequence to cross from control to intervention arm.

Other: Multi-component implementation intervention

Interventions

The multiple-component implementation intervention will comprise of 3 key components: (1) education, (2) operational process, and (3) audit and feedback

Hospital 1Hospital 2Hospital 3Hospital 4

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Affiliated to SingHealth
  • Currently using FMA in clinical practice by occupational therapists

You may not qualify if:

  • Use of FMA in clinical practice by occupational therapists funded by existing research grants
  • Not using FMA in clinical practice by occupational therapists

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Singapore General Hospital

Singapore, Singapore

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Silvana Choo, PhD

    Singapore General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Due to the nature of intervention, blinding may not be possible. However, occupational therapists at all 4 hospitals will be blinded to the allocation sequence, with only the next hospital randomised for rollout being revealed at each intervention implementation time point. This will allow for blinding to the intervention partially possible. The investigators will also remind occupational therapists at all 4 hospitals not disclose details about the intervention to other healthcare professionals until the end of the trial.
Purpose
OTHER
Intervention Model
SEQUENTIAL
Model Details: Hospital will be the unit of randomisation.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 10, 2022

First Posted

May 16, 2022

Study Start

July 6, 2022

Primary Completion

August 2, 2023

Study Completion

August 2, 2023

Last Updated

May 21, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations